Certara (NASDAQ:CERT) Shares Gap Up - Here's Why

Certara, Inc. (NASDAQ:CERT - Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $12.33, but opened at $13.08. Certara shares last traded at $12.41, with a volume of 191,824 shares traded.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. TD Cowen assumed coverage on Certara in a research report on Thursday. They set a "buy" rating and a $16.00 price target on the stock. Barclays lifted their price objective on Certara from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research report on Friday. Stephens reiterated an "overweight" rating and issued a $17.00 price objective on shares of Certara in a research report on Thursday. William Blair reiterated a "market perform" rating on shares of Certara in a research report on Thursday. Finally, Robert W. Baird cut their price objective on Certara from $18.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, November 5th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $15.83.

Certara Trading Down 0.3 %

The company has a market cap of $1.92 billion, a PE ratio of -59.70, a PEG ratio of 9.29 and a beta of 1.57. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.28. The stock has a 50 day moving average price of $12.48 and a 200 day moving average price of $11.63.

Remove Ads

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CERT. Mackenzie Financial Corp purchased a new position in Certara during the fourth quarter valued at $17,852,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Certara by 16.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,574 shares of the company's stock valued at $2,807,000 after buying an additional 37,870 shares during the last quarter. Voloridge Investment Management LLC raised its stake in Certara by 269.3% during the fourth quarter. Voloridge Investment Management LLC now owns 275,633 shares of the company's stock valued at $2,935,000 after buying an additional 201,003 shares during the last quarter. Squarepoint Ops LLC raised its stake in Certara by 62.7% during the fourth quarter. Squarepoint Ops LLC now owns 94,433 shares of the company's stock valued at $1,006,000 after buying an additional 36,386 shares during the last quarter. Finally, Two Sigma Advisers LP raised its stake in Certara by 35.7% during the fourth quarter. Two Sigma Advisers LP now owns 87,500 shares of the company's stock valued at $932,000 after buying an additional 23,000 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company's stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.